Company
Evolrix AI is an AI-driven biomanufacturing platform. Its AI-scientist agent, Kairos, delivers auditable dry-lab design today — sequence design, expression-construct optimization, and structure-confidence checks — with fermentation, scale-up, and purification on the roadmap. We believe biological design should be provable, traceable, and focused on what computation can reliably predict.
Mission
The old paradigm fragmented biomanufacturing: research here, process there, production elsewhere. Each stage rebuilt from scratch. AI changes this. We build a single platform whose AI-scientist agent, Kairos, reasons over verifiable tools, designs provably-correct sequences, and carries provenance from the first design to industrial scale-out.
Provable, traceable, re-runnable.
Every score is a re-runnable computation. Every design element carries its source. Nothing invented, nothing hidden.
Provable
Designs that are provably correct — verified by construction, not asserted.
Traceable
Every design element carries its source; every score is re-runnable.
Focused
Computation aimed where it delivers value today.
Company
Safety
Synthetic biology and AI are each powerful; together they demand deliberate safety practices. Read about our approach to biosecurity screening, dual-use review, and stated in-silico scope.
Milestones
Since first release in July 2026, Kairos has grown from a dry-lab research loop into an auditable workbench — cited evidence retrieval, ranked CDS design, in-silico structure checks, a downstream manufacturability panel, hypothesis-by-hypothesis verification, and an automated review layer that checks every claim against its sources. See the changelog for the version-by-version detail.
Bring one target sequence. Get a ranked, cited construct panel in minutes.